Takeda Provides Further Information about its New Business Venture with Teva

OSAKA, Japan & Jerusalem–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Takeda Pharmaceutical Company Limited (TSE: 4502) today made the below follow-up announcement regarding the overview of their new business venture in Japan which was initially disclosed on November 30, 2015 in the press release titled, “Teva and Takeda establish unique partnership to meet the wide-ranging needs of patients and growing importance of generic medicines use in Japan”. [http://ir
Source: BusinessWire-Primary
{inline_image}